{"id":454562,"date":"2021-03-10T07:08:05","date_gmt":"2021-03-10T12:08:05","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=454562"},"modified":"2021-03-10T07:08:05","modified_gmt":"2021-03-10T12:08:05","slug":"calithera-biosciences-to-report-fourth-quarter-2021-financial-results-on-tuesday-march-16-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/calithera-biosciences-to-report-fourth-quarter-2021-financial-results-on-tuesday-march-16-2021\/","title":{"rendered":"Calithera Biosciences to Report Fourth Quarter 2021 Financial Results on Tuesday, March 16, 2021"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SOUTH SAN FRANCISCO, Calif., March  10, 2021  (GLOBE NEWSWIRE) &#8212; Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, today\u00a0announced that the Company\u2019s fourth quarter 2020 financial results will be released on Tuesday, March 16, 2021. Company management will host a conference call on Tuesday, March 16, 2021 at 2:00 p.m. Pacific Time\/ 5:00 p.m. Eastern Time to discuss the financial results and other recent corporate highlights.<\/p>\n<p>The press release and live audio webcast can be accessed via the Investor section of the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TBmQ-3DLaBGz68sTMduLw6aJpEcZNADBTtqyplWeOIC-8ocgOLUb7DfjklguqmLDRtPn4cbCv51y-DQuZbNz8g==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.calithera.com<\/a>. The conference call can be accessed by dialing (855) 783-2599 (domestic) or (631) 485-4877 (international) and refer to conference ID 6250035. Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived webcast will remain available for replay on Calithera\u2019s website for 30 days.<\/p>\n<p>\n        <strong>About Calithera<\/strong>\n      <\/p>\n<p>Calithera Biosciences is a clinical-stage biopharmaceutical company pioneering the discovery and development of targeted therapies that disrupt cellular metabolic pathways to preferentially starve tumor cells and enhance immune-cell activity. Driven by a commitment to rigorous science and a passion for improving the lives of people impacted by cancer and other life-threatening diseases, Calithera is advancing a pipeline of first-in-clinic, oral therapeutics to meaningfully expand treatment options available to patients. Calithera is headquartered in South San Francisco, California. For more information about Calithera, please visit www.calithera.com.<\/p>\n<p>\n        <strong>Forward Looking Statements<\/strong>\n      <\/p>\n<p>Statements contained in this press release regarding matters that are not historical facts are &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;intend,&#8221; &#8220;poised&#8221; and similar expressions (as well as other words or expressions referencing future events, conditions, or circumstances) are intended to identify forward-looking statements. These statements include those related to the safety, tolerability and efficacy of Calithera\u2019s product candidates, the overall advancement of Calithera\u2019s product candidates in clinical trials, the unmet need in the treatment of patients with advanced disease, and Calithera\u2019s plans to continue development of its product candidates. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. The product candidates that Calithera develops may not progress through clinical development or receive required regulatory approvals within expected timelines or at all. In addition, clinical trials may not confirm any safety, potency or other product characteristics described or assumed in this press release. Such product candidates may not be beneficial to patients or successfully commercialized. The failure to meet expectations with respect to any of the foregoing matters may have a negative effect on Calithera&#8217;s stock price. Additional information concerning these and other risk factors affecting Calithera&#8217;s business can be found in Calithera&#8217;s most recent Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission, and other periodic filings with the Securities and Exchange Commission at www.sec.gov. These forward-looking statements are not guarantees of future performance and speak only as of the date hereof, and, except as required by law, Calithera disclaims any obligation to update these forward-looking statements to reflect future events or circumstances.<\/p>\n<p>\n        <strong>SOURCE<\/strong>:\u00a0Calithera Biosciences, Incorporated<\/p>\n<p>\n        <strong>CONTACT<\/strong>:<\/p>\n<p>Jennifer McNealey<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=W5jrVIVxMTRkGfaOuUOJs80wObo5w2pIudFU11BpGjRvmb0iqZ3VWX6C5MSIuRNHcKdNcD-hk28T57KAAh_Mew==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">ir@Calithera.com<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LjiHu13oqK679bOmdNmD27IPwc3X7CFE9RZ4SkEOpzDadhAzktitKIy9I0m5gEfY\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><br \/><\/a>650-870-1071<\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NjQ1NCM0MDU0MTQ3IzIwMDYwMzg=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/ec0627be-5454-4ab2-bd1f-89b9dd3ab501\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH SAN FRANCISCO, Calif., March 10, 2021 (GLOBE NEWSWIRE) &#8212; Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, today\u00a0announced that the Company\u2019s fourth quarter 2020 financial results will be released on Tuesday, March 16, 2021. Company management will host a conference call on Tuesday, March 16, 2021 at 2:00 p.m. Pacific Time\/ 5:00 p.m. Eastern Time to discuss the financial results and other recent corporate highlights. The press release and live audio webcast can be accessed via the Investor section of the Company\u2019s website at www.calithera.com. The conference call can be accessed by dialing (855) 783-2599 (domestic) or (631) 485-4877 (international) &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/calithera-biosciences-to-report-fourth-quarter-2021-financial-results-on-tuesday-march-16-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Calithera Biosciences to Report Fourth Quarter 2021 Financial Results on Tuesday, March 16, 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-454562","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Calithera Biosciences to Report Fourth Quarter 2021 Financial Results on Tuesday, March 16, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/calithera-biosciences-to-report-fourth-quarter-2021-financial-results-on-tuesday-march-16-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Calithera Biosciences to Report Fourth Quarter 2021 Financial Results on Tuesday, March 16, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif., March 10, 2021 (GLOBE NEWSWIRE) &#8212; Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, today\u00a0announced that the Company\u2019s fourth quarter 2020 financial results will be released on Tuesday, March 16, 2021. Company management will host a conference call on Tuesday, March 16, 2021 at 2:00 p.m. Pacific Time\/ 5:00 p.m. Eastern Time to discuss the financial results and other recent corporate highlights. The press release and live audio webcast can be accessed via the Investor section of the Company\u2019s website at www.calithera.com. The conference call can be accessed by dialing (855) 783-2599 (domestic) or (631) 485-4877 (international) &hellip; Continue reading &quot;Calithera Biosciences to Report Fourth Quarter 2021 Financial Results on Tuesday, March 16, 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/calithera-biosciences-to-report-fourth-quarter-2021-financial-results-on-tuesday-march-16-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-10T12:08:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NjQ1NCM0MDU0MTQ3IzIwMDYwMzg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calithera-biosciences-to-report-fourth-quarter-2021-financial-results-on-tuesday-march-16-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calithera-biosciences-to-report-fourth-quarter-2021-financial-results-on-tuesday-march-16-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Calithera Biosciences to Report Fourth Quarter 2021 Financial Results on Tuesday, March 16, 2021\",\"datePublished\":\"2021-03-10T12:08:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calithera-biosciences-to-report-fourth-quarter-2021-financial-results-on-tuesday-march-16-2021\\\/\"},\"wordCount\":555,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calithera-biosciences-to-report-fourth-quarter-2021-financial-results-on-tuesday-march-16-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NjQ1NCM0MDU0MTQ3IzIwMDYwMzg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calithera-biosciences-to-report-fourth-quarter-2021-financial-results-on-tuesday-march-16-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calithera-biosciences-to-report-fourth-quarter-2021-financial-results-on-tuesday-march-16-2021\\\/\",\"name\":\"Calithera Biosciences to Report Fourth Quarter 2021 Financial Results on Tuesday, March 16, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calithera-biosciences-to-report-fourth-quarter-2021-financial-results-on-tuesday-march-16-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calithera-biosciences-to-report-fourth-quarter-2021-financial-results-on-tuesday-march-16-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NjQ1NCM0MDU0MTQ3IzIwMDYwMzg=\",\"datePublished\":\"2021-03-10T12:08:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calithera-biosciences-to-report-fourth-quarter-2021-financial-results-on-tuesday-march-16-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calithera-biosciences-to-report-fourth-quarter-2021-financial-results-on-tuesday-march-16-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calithera-biosciences-to-report-fourth-quarter-2021-financial-results-on-tuesday-march-16-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NjQ1NCM0MDU0MTQ3IzIwMDYwMzg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NjQ1NCM0MDU0MTQ3IzIwMDYwMzg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calithera-biosciences-to-report-fourth-quarter-2021-financial-results-on-tuesday-march-16-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Calithera Biosciences to Report Fourth Quarter 2021 Financial Results on Tuesday, March 16, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Calithera Biosciences to Report Fourth Quarter 2021 Financial Results on Tuesday, March 16, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/calithera-biosciences-to-report-fourth-quarter-2021-financial-results-on-tuesday-march-16-2021\/","og_locale":"en_US","og_type":"article","og_title":"Calithera Biosciences to Report Fourth Quarter 2021 Financial Results on Tuesday, March 16, 2021 - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif., March 10, 2021 (GLOBE NEWSWIRE) &#8212; Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, today\u00a0announced that the Company\u2019s fourth quarter 2020 financial results will be released on Tuesday, March 16, 2021. Company management will host a conference call on Tuesday, March 16, 2021 at 2:00 p.m. Pacific Time\/ 5:00 p.m. Eastern Time to discuss the financial results and other recent corporate highlights. The press release and live audio webcast can be accessed via the Investor section of the Company\u2019s website at www.calithera.com. The conference call can be accessed by dialing (855) 783-2599 (domestic) or (631) 485-4877 (international) &hellip; Continue reading \"Calithera Biosciences to Report Fourth Quarter 2021 Financial Results on Tuesday, March 16, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/calithera-biosciences-to-report-fourth-quarter-2021-financial-results-on-tuesday-march-16-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-10T12:08:05+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NjQ1NCM0MDU0MTQ3IzIwMDYwMzg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/calithera-biosciences-to-report-fourth-quarter-2021-financial-results-on-tuesday-march-16-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/calithera-biosciences-to-report-fourth-quarter-2021-financial-results-on-tuesday-march-16-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Calithera Biosciences to Report Fourth Quarter 2021 Financial Results on Tuesday, March 16, 2021","datePublished":"2021-03-10T12:08:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/calithera-biosciences-to-report-fourth-quarter-2021-financial-results-on-tuesday-march-16-2021\/"},"wordCount":555,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/calithera-biosciences-to-report-fourth-quarter-2021-financial-results-on-tuesday-march-16-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NjQ1NCM0MDU0MTQ3IzIwMDYwMzg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/calithera-biosciences-to-report-fourth-quarter-2021-financial-results-on-tuesday-march-16-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/calithera-biosciences-to-report-fourth-quarter-2021-financial-results-on-tuesday-march-16-2021\/","name":"Calithera Biosciences to Report Fourth Quarter 2021 Financial Results on Tuesday, March 16, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/calithera-biosciences-to-report-fourth-quarter-2021-financial-results-on-tuesday-march-16-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/calithera-biosciences-to-report-fourth-quarter-2021-financial-results-on-tuesday-march-16-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NjQ1NCM0MDU0MTQ3IzIwMDYwMzg=","datePublished":"2021-03-10T12:08:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/calithera-biosciences-to-report-fourth-quarter-2021-financial-results-on-tuesday-march-16-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/calithera-biosciences-to-report-fourth-quarter-2021-financial-results-on-tuesday-march-16-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/calithera-biosciences-to-report-fourth-quarter-2021-financial-results-on-tuesday-march-16-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NjQ1NCM0MDU0MTQ3IzIwMDYwMzg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NjQ1NCM0MDU0MTQ3IzIwMDYwMzg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/calithera-biosciences-to-report-fourth-quarter-2021-financial-results-on-tuesday-march-16-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Calithera Biosciences to Report Fourth Quarter 2021 Financial Results on Tuesday, March 16, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/454562","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=454562"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/454562\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=454562"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=454562"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=454562"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}